Abstract Details

Title Antiparkinson drug use in response to practice parameter publication, drug availability, and ‘unofficial’ prescribing forces

Topic General Neurology

Presentation(s) (-)

Poster/Presentation
Number 149

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
James Crispo PRESENTER	No disclosure on file
David Y. Hwang, MD, F�鶹��ýӳ�� (University of North Carolina School of Medicine)	The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. The institution of an immediate family member of Dr. Hwang has received research support from NIH. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Director - Critical Care with New England Donor Services.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Eesha Oza, MD	Dr. Oza has nothing to disclose.
	No disclosure on file

�鶹��ýӳ��